日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stenotrophomonas promotes gastrointestinal tumor progression via STING degradation in tumour cells and mitigated immune response.

嗜麦芽窄食单胞菌通过降解肿瘤细胞中的 STING 和减弱免疫反应来促进胃肠道肿瘤的进展。

Feng Huolun, Chen Kunling, Xi Zhihui, Xia Baijin, Chen Xi, Huang Yiqin, Huang Zuda, Guo Jieqing, Zhu Dandan, Ling Fa, Zhou Jianlong, Zhang Yuhan, Zhang Yucheng, Liu Yongfeng, Zhang Wenxing, Lin Jiatong, Lyu Zejian, Huang Qunsheng, Wang Junjiang, Hou Tieying, Zheng Jiabin, Xing Fan, Li Yong

Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8(+) T cell immunity via rewiring MHC-I antigen presentation

经基因工程改造的溶瘤病毒携带抗PCSK9 scFv,可通过重塑MHC-I抗原呈递途径增强长期CD8(+) T细胞免疫力

Feng, Huolun; Zhang, Yuhan; Huang, Zuda; Zhou, Jianlong; Liu, Yongfeng; Xiao, Xiao; Chen, Mingxi; Guo, Xin; Zheng, Jiabin; Lyu, Zejian; Hu, Weixian; Wu, Deqing; Li, Yong; Xing, Fan

EZH2 inhibition and 5-azacytidine enhance antitumor immunity in PTEN-deficient glioblastoma by activation viral mimicry response

EZH2抑制剂和5-氮杂胞苷通过激活病毒模拟反应增强PTEN缺陷型胶质母细胞瘤的抗肿瘤免疫力。

Zhu, Dandan; Li, Zeying; Feng, Huolun; Zheng, Jiabin; Xiao, Xiao; Huang, Zuda; Zheng, Liangying; Guo, Jieqing; Ling, Fa; Li, Yong; Xing, Fan

Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer.

靶向 TBK1 可通过增强 ICAM1 介导的 NK 细胞免疫力来增强溶瘤病毒疗法在化疗耐药性结直肠癌中的疗效

Guo Xin, Feng Huolun, Xi Zhihui, Zhou Ji, Huang Zuda, Guo Jieqing, Zheng Jiabin, Lyu Zejian, Liu Yongfeng, Zhou Jianlong, Zhang Yucheng, Zhang Yuhan, Li Yong, Xing Fan

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors

cGAS-STING通路介导树突状细胞对免疫原性肿瘤的感知激活

Li, Guohao; Zhao, Xiangqian; Zheng, Zuda; Zhang, Hucheng; Wu, Yundi; Shen, Yangkun; Chen, Qi

Analysis of Adverse Reactions of Cosmetics in Chinese Han Population in Recent Five Years

近五年来中国汉族人群化妆品不良反应分析

Dong, Canbin; Liu, Fang; Liao, Zuda; Lin, Lanmei; Wang, Runnan; Du, Juan; Huang, Wen